EMCDDA. Resources on COVID-19 and drug markets
EMCDDA. Resources on COVID-19 and drug markets
The EMCDDA is producing a series of special reports and briefings on the impact of the COVID-19 pandemic on drug markets. COVID-19 and the related government responses are likely to precipitate impacts that have never been observed before and have therefore not been studied. Currently, there is a lack of data and research to inform the understanding at European and international level on the measures taken by drug producers, traffickers and suppliers, when significant global events cause disruption to the supply chain. Such disruptions can have important implications for patterns of drug use within the EU, the associated health, social and security problems, and for policy and operational responses. (EMCDDA, Lissabon, 28.05.2020)
https://www.emcdda.europa.eu/publications/ad-hoc-publication/covid-19-and-drug-markets-resources/html_en